Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Rank in Stocks #5443
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Share Price
$90.29
Last synced: 2026-08-26
Market Cap
$2.69B
Change (1 day)
3.30%
Change (1 year)
-30.11%
Country
US
Trade GeneDx Holdings Corp. (WGS)

Category

Price of WGS with the market cap of B
GeneDx Holdings Corp. GeneDx Holdings Corp.
WGS
$90.29
Market Capitalization of GeneDx Holdings Corp.(WGS)
Market Cap: $2.69B
As of August 2026 GeneDx Holdings Corp. has a market cap of $2.69B. This makes GeneDx Holdings Corp. the world's 5443rd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of GeneDx Holdings Corp. from 2020 to 2026
WGS compared with Top 5 Most Popular stocks
Price of WGS Asset B Mkt. of B Results
GeneDx Holdings Corp. GeneDx Holdings Corp.
$170,605 $2.69B
$5.088T +188,852.11%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$155,221 $2.69B
$4.629T +171,814.17%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$138,070 $2.69B
$4.118T +152,818.30%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$123,622 $2.69B
$3.687T +136,816.39%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$93,876.87 $2.69B
$2.800T +103,872.61%